
|Articles|June 21, 2021
- June 2021
- Volume 27
- Issue 4
Weidner et al, Appendices
Appendices to: Observations Regarding the Average Sales Price Reimbursement Methodology
Advertisement
Articles in this issue
over 4 years ago
Dollars and Senseover 4 years ago
Real-World Evidence Is Key to Accelerating Oncology Approvalsover 4 years ago
Biosimilars Drive Savings in Medicare’s Oncology Care Modelover 4 years ago
A Social Worker Leads ACCC, and Her Timing Is PerfectNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Trump Announces Deals With Lilly, Novo to Cut Weight Loss Drug Prices
2
CMS Announces GENEROUS Model to Lower Medicaid Drug Prices
3
Medicare Advantage Reimbursement Structures Impact Home Health Delivery and Outcomes
4
FDA Approves Daratumumab and Hyaluronidase-fihj for High-Risk MM
5















































